Pharma
Now that the U.S. Healthcare bill has passed and just been signed into law, it’s interesting to notice the amount of noise generated in the past two days. Newspaper and sell-side reports are booming with articles and so-called analysis of what this means to investors, but right now it’s probably better to “do something by doing nothing”.
